Enhertu is recommended for breast cancer at 5.4 mg/kg once every three weeks and for gastric cancer at 6.4 mg/kg once every three weeks, up until the development of the disease or the occurrence of unacceptable effects. Don't wait until the following cycle to administer if a scheduled dose is forgotten or delayed. Adapt the delivery schedule to keep a 3-week gap between doses. Use the dose and rate that the patient tolerated for the most recent infusion while administering the infusion.
Enhertu 100mg is economical through The Indian Pharma, the licensed drug supplier that comes in a single-dose vial with 100 mg lyophilized powder. To know more, visit https://theindianpharma.com/tr....astuzumab-deruxtecan
Like
Comment
Share
